<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0035">
 <label>7</label>
 <element-citation publication-type="journal" id="h0035">
  <person-group person-group-type="author">
   <name>
    <surname>Lambert</surname>
    <given-names>P.H.</given-names>
   </name>
   <name>
    <surname>Ambrosino</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Andersen</surname>
    <given-names>S.R.</given-names>
   </name>
  </person-group>
  <article-title>Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines</article-title>
  <source>Vaccine</source>
  <volume>38</volume>
  <issue>31</issue>
  <year>2020</year>
  <fpage>4783</fpage>
  <lpage>4791</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2020.05.064</pub-id>
  <comment>PubMED PMID: 32507409. PubMED PMCID: "
   <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7247514/" id="ce.inter-ref_r4l_mst_mmb" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7247514/</ext-link>" PMC7247514
  </comment>
  <pub-id pub-id-type="pmid">32507409</pub-id>
 </element-citation>
</ref>
